Skip to main content
SpringerLink
Log in

Heart Failure Morbidity, Mortality, and Its Relationship to Hypertension

  • Chapter
  • First Online:
Hypertension in High Risk African Americans

Part of the book series: Clinical Hypertension and Vascular Diseases ((CHVD))

  • 680 Accesses

Abstract

Heart failure (HF) remains a significant cardiovascular problem, with increasing incidence and prevalence rates: Adult Americans over 40 years of age have a 20 % lifetime risk of developing heart failure. Approximately five million people in the USA have HF, and over 650,000 new cases of HF are diagnosed each year. HF incidence increases with age: from 20 per 1,000 among individuals 65–69 years of age to greater than 80 per 1,000 for individuals who are over 85 years of age.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yancy CW, Jessup M, Bozkurt B, Masoudi FA, Butler J, McBride PE, Casey Jr DE, McMurray JJ, Drazner MH, Mitchell JE, Fonarow GC, Peterson PN, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:1810–52.

    Article  PubMed  Google Scholar 

  2. Djousse L, Driver JA, Gaziano JM. Relation between modifiable life-style factors and lifetime risk of heart failure. JAMA. 2009;302:394–400.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.

    Article  PubMed  Google Scholar 

  4. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994–2003. Arch Intern Med. 2008;168:418–24.

    Article  PubMed  Google Scholar 

  5. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004;292:344–50.

    Article  CAS  PubMed  Google Scholar 

  6. Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2:407–13.

    Article  PubMed  Google Scholar 

  7. Bueno H, Ross JS, Wang Y, et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993–2006. JAMA. 2010;303:2141–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. The booming dynamics of aging: from awareness to action. The White House Conference on Aging. Washington, DC: US Department of Health and Human Services; 2011.

    Google Scholar 

  9. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–402.

    Article  PubMed  Google Scholar 

  10. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–72.

    Article  PubMed  Google Scholar 

  11. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829–33.

    Article  CAS  PubMed  Google Scholar 

  12. Mosterd A, Hoes AW, de Bruyne MC, et al. Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study. Eur Heart J. 1999;20:447–55.

    Article  CAS  PubMed  Google Scholar 

  13. Bahrami H, Kronmal R, Bluemke DA, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168:2138–45.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Loehr LR, Rosamond WD, Chang PP, et al. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol. 2008;101:1016–22.

    Article  PubMed  Google Scholar 

  15. Franciosa JA, Ferdinand KC, Yancy CW. Treatment of heart failure in African Americans: a consensus statement. Congest Heart Fail. 2010;16:27–38.

    Article  PubMed  Google Scholar 

  16. Yancy C. Heart failure in African Americans: unique etiology and pharmacologic treatment responses. J Natl Med Assoc. 2003;95:1–12.

    PubMed Central  PubMed  Google Scholar 

  17. Ofili EO, Mayberry R, Alema-Mensah E, Saleem S, Hamirani K, Jones C, Salih S, Lankford B, Igho-Pemu P. Risk factors for frequent hospitalization for heart failure in an urban center serving predominantly African American patients: gender differences and practice implications. Am J Cardiol. 1999;83:1350–5.

    Article  CAS  PubMed  Google Scholar 

  18. Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, Dzudie A, Kouam CK, Suliman A, Schrueder N, Yonga G, Ba SA, Maru F, Alemayehu B, Edwards C, Davison BA, Cotter G, Sliwa K. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the sub-Saharan Africa Survey of Heart Failure. Arch Intern Med. 2012;172(18):1386–94.

    Article  CAS  PubMed  Google Scholar 

  19. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Eugene Braunwald E, O’Connor CM, NHLBI Heart Failure Clinical Research Network. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797–805.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Bart BA, Goldsmith SR, Lee KL, Givertz MK, O’Connor CM, David A, Bull DA, Redfield RM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367(24):2296–304.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557–62.

    Article  CAS  PubMed  Google Scholar 

  22. Lapu-Bula R, Ofili E. Diastolic heart failure: the forgotten manifestation of hypertensive heart disease. Curr Hypertens Rep. 2004;6:164–70.

    Article  PubMed  Google Scholar 

  23. Vasan RS, Levy D. The role of hypertension in the pathogenesis of heart failure: a clinical mechanistic overview. Arch Intern Med. 1996;156:1789–96.

    Article  CAS  PubMed  Google Scholar 

  24. Aeschbacher BC, Hutter D, Fuhrer J, Weidmann P, Delacretaz E, Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens. 2001;14:106–13.

    Article  CAS  PubMed  Google Scholar 

  25. Mo R, Nordrehaug JE, Omvik P, Lung-Johansen P. The Bergen Blood Pressure Study: prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Press. 1995;4:16–22.

    Article  CAS  PubMed  Google Scholar 

  26. Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17–22.

    Article  CAS  PubMed  Google Scholar 

  27. Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, Bauersachs J. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Circulation. 2008;118:818–27.

    Article  CAS  PubMed  Google Scholar 

  28. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res. 2004;94:1256–62.

    Article  CAS  PubMed  Google Scholar 

  29. Kass DA, Takimoto E, Nagayama T, Champion HC. Phosphodiesterase regulation of nitric oxide signaling. Cardiovasc Res. 2007;75:303–14.

    Article  CAS  PubMed  Google Scholar 

  30. Rohde D, Ritterhoff J, Voelkers M, Katus HA, Parker TG, Most P. S100A1: a multifaceted therapeutic target in cardiovascular disease. J Cardiovasc Transl Res. 2010;3:525–37.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Li R, Lyn D, Lapu-Bula R, Oduwole A, Igho-Pemu P, Lankford B, Morgan J, Nkemdechi S, Liu G, Pack C, Silvestrov N, von Deutsch DA, Song Q, Abukhalaf IK, Ofili E. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am J Hypertens. 2004;17:560–7.

    Article  CAS  PubMed  Google Scholar 

  32. Lapu-Bula R, Quarshie A, Lyn D, Oduwole A, Pack C, Morgan J, Nkemdiche S, Igho-Pemu P, Onwuanyi A, Li R, Ofili E. The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure. J Natl Med Assoc. 2005;97:197–205.

    PubMed Central  PubMed  Google Scholar 

  33. Lapu-Bula R, Ofili E. From hypertension to heart failure: role of nitric oxide-mediated endothelial dysfunction and emerging insights from myocardial contrast echocardiography. Am J Cardiol. 2007;99:7D–14.

    Article  CAS  PubMed  Google Scholar 

  34. Lapu-Bula R, Onwuanyi A, Bielo M, Deffer O, Quarshie A, Alema-Mensah E, Cross A, Oduwole A, Ofili E. Risk factors for acute non-ST-segment elevation myocardial infarction in a population sample of predominantly African American patients with chest pain and normal coronary arteries. Ethn Dis. 2011;21(4):421–8.

    PubMed Central  PubMed  Google Scholar 

  35. Hare J. Nitroso-redox balance in the cardiovascular system. N Engl J Med. 2004;351:2112–4.

    Article  CAS  PubMed  Google Scholar 

  36. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87–104.

    Article  CAS  PubMed  Google Scholar 

  37. Taylor AL. The African-American Heart Failure Trial (A-HeFT): rationale and methodology. J Card Fail. 2003;9:S216–9.

    Article  PubMed  Google Scholar 

  38. Taylor AL, Ziesche S, Yancy C, Carson P, D’Agostino R, Ferdinand KC, Taylor M, Adams K, Sabolinski ML, Worcel M, Cohn JN. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351:2049–57.

    Article  CAS  PubMed  Google Scholar 

  39. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986;314:1547–52.

    Article  CAS  PubMed  Google Scholar 

  40. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303–10.

    Article  CAS  PubMed  Google Scholar 

  41. Carson P, Ziesche S, Johnson G, Cohn JN. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group. J Card Fail. 1999;5:178–87.

    Article  CAS  PubMed  Google Scholar 

  42. Taylor AL, Ziesche S, Yancy CW, Carson P, Ferdinand K, Taylor M, Adams K, Olukotun AY, Ofili E, Tam SW, Sabolinski ML, Worcel M, Cohn JN. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial. Circulation. 2007;115:1747–53.

    Article  CAS  PubMed  Google Scholar 

  43. Cohn JN, Tam SW, Anand IS, Taylor AL, Sabolinski ML, Worcel M. Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT. J Card Fail. 2007;13:331–9.

    Article  CAS  PubMed  Google Scholar 

  44. Heo S, Doering LV, Widener J, et al. Predictors and effect of physical symptom status on health-related quality of life in patients with heart failure. Am J Crit Care. 2008;17:124–32.

    PubMed  Google Scholar 

  45. Lesman-Leegte I, Jaarsma T, Coyne JC, et al. Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls. J Card Fail. 2009;15:17–23.

    Article  PubMed  Google Scholar 

  46. Moser DK, Yamokoski L, Sun JL, et al. Improvement in health-related quality of life after hospitalization predicts event-free survival in patients with advanced heart failure. J Card Fail. 2009;15:763–9.

    Article  PubMed Central  PubMed  Google Scholar 

  47. Rodriguez-Artalejo F, Guallar-Castillon P, Pascual CR, et al. Health related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med. 2005;165:1274–9.

    Article  PubMed  Google Scholar 

  48. Anand IS, Tam SW, Rector TS, Taylor AL, Sabolinski ML, Archambault WT, Adams KF, Olukotun AY, Worcel M, Cohn JN. Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol. 2007;49(1):32–9. Epub 2006 Dec 14.

    Article  CAS  PubMed  Google Scholar 

  49. Fonarow GC, Yancy CW, Hernandez AF, Peterson ED, Spertus JA, Heidenreich PA. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J. 2011;161:1024–30.e3.

    Article  PubMed  Google Scholar 

  50. Yancy CW, Abraham WT, Albert NM, Clare R, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, She L, Sun JL, Young JB, Fonarow GC. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol. 2008;51:1675–84.

    Article  PubMed  Google Scholar 

  51. Thomas KL, Hernandez AF, Dai D, Heidenreich P, Fonarow GC, Peterson ED, Yancy CW. Association of race/ethnicity with clinical risk factors, quality of care, and acute outcomes in patients hospitalized with heart failure. Am Heart J. 2011;161:746–54.

    Article  PubMed  Google Scholar 

  52. Golwala HB, Thadani U, Liang L, Stavrakis S, Butler J, Yancy CW, Bhatt DL, AdriHernandez AF, Fonarow GC. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc. 2013;2:e000214. doi:10.1161/JAHA.113. 000214.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O’Connor CM, Reynolds D, Walsh MN. Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF). Am J Cardiol. 2010;105:255–60.

    Article  PubMed  Google Scholar 

  54. Bonow RO, Ganiats TG, Beam CT, Blake K, Casey Jr DE, Goodlin SJ, Grady KL, Hundley RF, Jessup M, Lynn TE, Masoudi FA, Nilasena D, Pina IL, Rockswold PD, Sadwin LB, Sikkema JD, Sincak CA, Spertus J, Torcson PJ, Torres E, Williams MV, Wong JB. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement. Circulation. 2012;125:2382–401.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Clinical Research Center, Morehouse School of Medicine, Atlanta, GA, 30310, USA

    Elizabeth O. Ofili M.D., M.P.H., F.A.C.C., Rigobert Lapu Bula M.D., Ph.D., Adesoji Oderinde M.D., M.S.C.R. & Adefisayo Oduwole

Authors
  1. Elizabeth O. Ofili M.D., M.P.H., F.A.C.C.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rigobert Lapu Bula M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adesoji Oderinde M.D., M.S.C.R.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adefisayo Oduwole
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth O. Ofili M.D., M.P.H., F.A.C.C. .

Editor information

Editors and Affiliations

  1. Cardiology, Tulane University School of Medicine, New Orleans, Louisiana, USA

    Keith C. Ferdinand

Acknowledgement

Acknowledgement

Dr Ofili is supported by the National Institutes of Health, Grant Numbers: U54MD008149; 8 U54 MD007588; U54MD008173; and U54MD008173 from the National Institute on Minority Health and Health Disparities (NIMHD) and Grant Number UL1TR000454 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH) NIMHD or NCATS.

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ofili, E.O., Bula, R.L., Oderinde, A., Oduwole, A. (2015). Heart Failure Morbidity, Mortality, and Its Relationship to Hypertension. In: Ferdinand, K. (eds) Hypertension in High Risk African Americans. Clinical Hypertension and Vascular Diseases. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2010-5_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2010-5_7

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-2009-9

  • Online ISBN: 978-1-4939-2010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation